Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia

Overview of attention for article published in Journal of Clinical Investigation, March 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
twitter: 4 X users

patent: 3 patents
guideline: 1 clinical guideline source

Readers on

mendeley: 149 Mendeley

So far, Altmetric has seen 5 news stories from 5 outlets.

DNA alterations may predict treatment response in chronic myelomonocytic leukemia patients

Today Topics , 02 Apr 2015

Chronic myelomonocytic leukemia (CMML) is a relatively rare cancer of the blood that primarily affects adults. The underlying…

DNA alterations may predict treatment response in chronic myelomonocytic leukemia patients

Medical News Today, 02 Apr 2015

Chronic myelomonocytic leukemia (CMML) is a relatively rare cancer of the blood that primarily affects adults.

Panel predicts whether rare leukemia will respond to treatment

Science Daily, 30 Mar 2015

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer…

Panel predicts whether rare leukemia will respond to treatment

MedicalXpress, 30 Mar 2015

Patients with chronic myelomonocytic leukemia have limited treatment options, and those that exist are effective only in fewer…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 1 additional news stories.